Hi everyone! It's been 7 weeks since I last wrote an issue of Glance, and I'm so happy to be back! Let's start with a rundown of some recent headlines.

There’s a new lens coming to town.

CooperVision’s new Biofinity toric multifocal should be arriving at your door soon.

Which specialty lost the most patient volume during the COVID-19 pandemic?

If you said ophthalmology, you are correct!

You know the occasional patient who fogs up the phoropter?

You're about to be on another level now that every patient is wearing a mask. Learn a few tricks to avoid this.


How exactly does COVID-19 get into the eye?

Specifically, via the ACE-2 protein.

The background:

SARS-CoV-2 has been found to latch onto ACE-2 receptors. These receptors are found in the respiratory tract and the lungs, which is where the virus first infiltrates cells, as well as other organs.

What about the eye?

New research out of Johns Hopkins University School of Medicine found that the ocular surface produces this ACE-2 protein, making it a target for the virus. According to the research team, if droplets from an infected person's sneeze or cough were to land on the surface of the eye, the virus could begin infiltrating cells there. Tears may also serve as a spread of infection. (via)


Any Rothy’s fans out there?

The company is offering a 50% off discount for frontline workers. Get your code here.

Is your mask bothering your ears?

Here is a creative fix.

1-800 Contacts is now doing boomerangs ... but not the cool kind.

1-800 Contacts unveiled Boomerang, an online lens replacement service that provides consumers with new lenses to put in their current glasses without having to visit an eye doctor or optical shop. (via)

See you next week!